Physician profile
David S Libson
NPI 1558368324
$493.13
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $50.27 · 2021: $79.72 · 2022: $140 · 2023: $94.27 · 2024: $18.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $166.19 | 2019-2023 | Tymlos |
| Amgen INC. | $55.34 | 2019-2020 | |
| Pfizer INC. | $49.60 | 2021-2023 | |
| Ethicon US, LLC | $39.76 | 2022-2023 | Echelon Flex |
| Agile Therapeutics, INC. | $34.08 | 2022-2023 | Twirla |
| Organon LLC | $32.44 | 2023-2024 | Nexplanon |
| Avion Pharmaceuticals | $32.17 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $22.65 | 2022 | |
| Exeltis, USA INC. | $19.06 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.96 | 2019 | |
| Myovant Sciences INC. | $13.80 | 2021 | |
| Mission Pharmacal Company | $13.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Libson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.